Subthalamic nucleus deep brain stimulation (STN DBS) is an effective treatment for Parkinson disease. Although the breadth and severity of neurobehavioral changes with STN DBS is debated, the frequency of serious adverse events is probably low. New research has identified patient characteristics that predict cognitive and emotional morbidity after STN DBS.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Smeding, H. M., Speelman, J. D., Huizenga, H. M., Schuurman, P. R. & Schmand, B. Predictors of cognitive and psychosocial outcome after STN DBS in Parkinson's Disease. J. Neurol. Neurosurg. Psychiatry 82, 754–760 (2011).
Rodriguez-Oroz, M. C. et al. Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up. Brain 128, 2240–2249 (2005).
Parsons, T. D., Rogers, S. A., Braaten, A. J., Woods, S. P. & Troster, A. I. Cognitive sequelae of subthalamic nucleus deep brain stimulation in Parkinson's disease: a meta-analysis. Lancet Neurol. 5, 578–588 (2006).
Witt, K. et al. Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson's disease: a randomised, multicentre study. Lancet Neurol. 7, 605–614 (2008).
York, M. K. et al. Cognitive declines following bilateral subthalamic nucleus deep brain stimulation for the treatment of Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 79, 789–795 (2008).
Weaver, F. M. et al. Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: a randomized controlled trial. JAMA 301, 63–73 (2009).
Williams, A. et al. Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson's disease (PD SURG trial): a randomised, open-label trial. Lancet Neurol. 9, 581–591 (2010).
Voon, V. et al. A multicentre study on suicide outcomes following subthalamic stimulation for Parkinson's disease. Brain 131, 2720–2728 (2008).
Strutt, A. M., Simpson, R., Jankovic, J. & York, M. K. Changes in cognitive-emotional and physiological symptoms of depression following STN-DBS for the treatment of Parkinson's disease. Eur. J. Neurol. http://dx.doi.org/10.1111/j.1468-1331.2011.03447.x.
Voon, V. et al. Psychiatric symptoms in patients with Parkinson disease presenting for deep brain stimulation surgery. J. Neurosurg. 103, 246–251 (2005).
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The author has acted as a consultant for Boston Scientific, Medtronic and St Jude Medical, has been a member of a speakers bureau for Medtronic and St Jude Medical and received grant or research support from Medtronic.
Rights and permissions
About this article
Cite this article
Tröster, A. Deep brain stimulation and neuropsychology: a step forward?. Nat Rev Neurol 7, 480–481 (2011). https://doi.org/10.1038/nrneurol.2011.122
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrneurol.2011.122
